# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012720
Filing Date
2020-11-05
Accepted
2020-11-05 08:06:59
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ardx-20200930x10q.htm iXBRL | 10-Q | 1993909
2 | EX-31.1 | ardx-20200930xex31d1.htm | EX-31.1 | 15522
3 | EX-31.2 | ardx-20200930xex31d2.htm | EX-31.2 | 15528
4 | EX-32.1 | ardx-20200930xex32d1.htm | EX-32.1 | 12034
| Complete submission text file | 0001558370-20-012720.txt |  | 6615096

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | ardx-20200930.xsd | EX-101.SCH | 47120
6 | EX-101.CAL | ardx-20200930_cal.xml | EX-101.CAL | 50032
7 | EX-101.DEF | ardx-20200930_def.xml | EX-101.DEF | 143218
8 | EX-101.LAB | ardx-20200930_lab.xml | EX-101.LAB | 346728
9 | EX-101.PRE | ardx-20200930_pre.xml | EX-101.PRE | 282657
10 | EXTRACTED XBRL INSTANCE DOCUMENT | ardx-20200930x10q_htm.xml | XML | 1150263

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 201288790
SIC: 2834 Pharmaceutical Preparations